7
total announcements
524414.BO · 15 min delayed
Norris Medicines Ltd
Norris Medicines Ltd has announced the outcome of its Board Meeting held on 03rd September, 2026, where the Board approved various matters including the Directors Report, closure of Register of Members, and convening of the 35th Annual General Meeting.
Norris Medicines Ltd
Norris Medicines Ltd has appointed Mr. Vimal Dhirendra Shah as Managing Director (Promoter and Executive) for a term of 3 years effective from September 1, 2026. The appointment is subject to shareholder approval.
Norris Medicines Ltd
Norris Medicines Ltd has announced its un-audited financial results for the quarter ended June 30, 2026, along with the appointment of Mr. Vimal Dhirendra Shah as a Managing Director for a term of 3 years. The company has also disclosed the details required under Regulation 30 of the Listing Regulations.
Norris Medicines Ltd
Norris Medicines Ltd has announced its un-audited financial results for the quarter ended June 30, 2026, along with the appointment of Mr. Vimal Dhirendra Shah as the Managing Director for a term of 3 years, effective from September 1, 2026.
Norris Medicines Ltd
Norris Medicines Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/08/2026 to consider and approve Unaudited Financial Results for the quarter ended June 30, 2026.
Norris Medicines Ltd
Norris Medicines Ltd has appointed Mr. Iqubal Ismail Patel as Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the Company, effective July 30, 2026. Mr. Patel has over 11 years of experience in finance, accounts, taxation, budgeting, financial planning, and corporate management.
Norris Medicines Ltd
Norris Medicines Ltd has appointed Mr. Iqubal Ismail Patel as Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the company, effective July 30, 2026.